DePuy Synthes Improvement Driven by Quicker U.S. Recovery

DePuy Synthes' logo

DePuy Synthes reported 3Q20 orthopedic revenue of USD $2,082 million, -2.6% vs. 3Q19. While COVID continues to impact the orthopedic market, procedures resumed more broadly around the world and brought significant improvement in the third quarter. Johnson & Johnson’s Medical Devices franchise saw the fastest recoveries in the U.S. and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us